Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Saba NF et al. – These findings elucidate the differential expression pattern of COX–2 in stages of head and neck premalignant lesions and invasive carcinoma, supporting the rationale for COX–2 inhibition as an important strategy for cancer chemoprevention. Further validation of COX–2 expression is needed in prospective ongoing chemoprevention trials.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address